Day: May 19, 2020

AUSTIN, Texas, May 19, 2020 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced it will present a new 56 week analysis on patients who have been treated with pegzilarginase from the completed Phase 1/2 clinical trial and the ongoing Phase 2 open-label extension study in a late-breaking oral presentation at the 6th Congress of the European Academy of Neurology being held virtually May 23-26, 2020.Presentation Details:Title: 1 Year Data from First in Human Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency (ARG1-D)Session: Late Breaking NewsPresentation Date: Monday, May 25, 2020, 5:15-6:30pm CEST (11:15am-12:30pm EDT)An electronic...

STOCKHOLM, SWEDEN and SEATTLE, WA, MAY 19, 2020 – We have all been restricted, more isolated, more lonely, during Covid-19 than anytime in modern history. Many have lost loved ones. Others are fighting on the frontline, putting themselves in harm’s way for the rest of us.Through the world’s first texting switchboard, you can now send a message of unconditional support to a stranger or a frontline hero – and get one in return. Alongside regular text messaging, the service is now also available on WhatsApp and Facebook Messenger.The Text For Humanity switchboard, created by Sinch in partnership with Mental Health America (MHA), originally launched in January to combat online negativity and promote the sharing of positive messages. To date, more than 83,000 messages of positivity have been exchanged across 85 countries.As the world moves...

AUSTIN, Texas, May 19, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ: CHUY) today announced that it will host a conference call to discuss first quarter 2020 financial results on Thursday, May 21, 2020 at 5:00 PM Eastern Time. A press release with first quarter 2020 financial results will be issued that same day after the market close.  Hosting the call will be Steve Hislop, President and Chief Executive Officer, and Jon Howie, Vice President and Chief Financial Officer.The conference call can be accessed live over the phone by dialing 877-407-0789 or for international callers by dialing 201-689-8562.  A replay will be available after the call and can be accessed by dialing 844-512-2921 or for international callers by dialing 412-317-6671; the passcode is 13704202. The replay will be available until Thursday, May 28, 2020.The...

All amounts in U.S. dollars unless otherwise stated TORONTO, May 19, 2020 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) announced that Onex Credit Partners, LLC (“Onex Credit”) priced its 18th U.S. collateralized loan obligation (“CLO”) for approximately $400 million. The transaction will be issued by a special purpose vehicle, backed by a diversified portfolio of broadly syndicated leveraged loans. The CLO is expected to close on May 28, 2020.CLO-18 will be managed by the Onex Credit team led by Paul Travers. The transaction will be supported by a diverse investor group from across the globe. This is the firm’s twenty-first CLO, having also issued three European CLOs, since it launched its CLO platform in 2012.Despite facing a very difficult market for CLO liability issuance, Onex has continued to identify opportunities...

San Jose, CA, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sonasoft Corp. (OTCQB: SSFT) is pleased to announce the successful completion of their proof of concept with Delaware Electric Cooperative (DEC). The PoC leveraged NuGene, Sonasoft’s AI Bot Engine, to give accurate demand forecasts. The PoC demonstrated that NuGene can deliver annual cost savings of up to $1.3m. As a result, DEC has green-lighted a move to production starting June 1st.“We must adapt to the wants and needs of our members,” said Bill Andrew, President and CEO of DEC. “They want quality power, minimal interruptions, competitive costs, and immediate response. I am 100% convinced that AI is key to our future success and existence. The potential for AI applications is endless. I see applications that include operations, engineering, customer service,...

BERKELEY, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways for the treatment of cancer, autoimmune and inflammatory diseases, today announced that the company will host a live conference call and webcast on Monday, June 8, 2020 at 1:00 pm PDT to report data in healthy volunteers from the ongoing Phase 1 study of BION-1301 for the treatment of IgA nephropathy (IgAN) as well as data from long-term nonclinical studies. Members of the Aduro executive team will be joined by Dr. Jonathan Barratt, the Mayer Professor of Renal Medicine at University of Leicester.Details of the BION-1301 abstracts accepted as poster presentations are...

COLUMBUS, Ohio, May 19, 2020 (GLOBE NEWSWIRE) — Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or the “Company“) announced today that an event of default has occurred in respect of its US$45.5 million principal amount of 15.00% secured convertible debentures, which matured on May 17, 2020.  As previously disclosed, on May 5, 2020 the Company received US$400,000 of debt financing from All Js Greenspace LLC (“All Js’) on a secured basis. On May 12, 2020, All Js’ advanced an additional US$400,000 to the Company, also on a secured basis.About Green Growth Brands Inc.Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida....

Til NASDAQ OMX Copenhagen A/S                                                          GlobeNewswire                                                                                                                         Faaborg, den 19. maj 2020                                                                                                                    Selskabsmeddelelse nr. 7/2020                                                               Opdatering af forventninger til 2020I selskabsmeddelelse nr. 3 af 25. marts 2020 suspenderede SKAKO sine forventninger til 2020 på grund af den store usikkerhed om Covid-19’s påvirkning af SKAKO’s forretning i 2020. På baggrund af de foreløbige resultater for 1. kvartal 2020 og en forventet lavere usikkerhed vedrørende Covid-19’s påvirkning af SKAKO’s forretning opdaterer SKAKO nu forventningerne...

Company Expects to Initiate Phase 1/2 Trial of NT-219 as Monotherapy Treatment of Advanced Solid Tumors and in Combination with cetuximab for Treatment of Recurrent or Metastatic Solid Tumors and Head and Neck CancerTEL AVIV, Israel, May 19, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that preclinical data for NT219, a novel agent addressing treatment resistance in advanced cancer, will be presented in a poster at the American Association of Cancer Research (AACR) Virtual Meeting II.The presentation, titled, “NT219, a novel dual inhibitor of STAT3 and IRS1/2, demonstrates anti-tumor activity with and without cetuximab in pembrolizumab-resistant head and neck cancer PDX models,”...